Latest Ratings for BDSX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2021 | Morgan Stanley | Downgrades | Overweight | Equal-Weight |
| May 2021 | Morgan Stanley | Maintains | Overweight | |
| Mar 2021 | Morgan Stanley | Maintains | Overweight |
Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
